Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Bill and Melinda Gates Foundation and the Ewing Kauffman Foundation. Next Ariel started two new ventures, one was to help track scholarly output of medical students, Labspot, and the other was a joint venture with Shore Group to collect data to help scientists at universities make decisions. Shore Group, acquired both Labspot and GreenSight. H1 then started. H1, led by Ariel, is a platform of every doctor globally used by the healthcare community to improve the way it develops drugs and devices.


DAY 1 / ‏‏‎ ‎

4:25 PM - 5:00 PM
Plenary View Session

Spotlight Presentations (max 6)

Each speaker presents a concise and fast-paced 5-minute presentation that will introduce you to an innovative way of solving a problem, a new technology or tool, or a transformative approach to solving common issues facing biopharma companies today. Immediately following the spotlight presentations, attendees can meet with these innovative companies in a relaxed atmosphere during the evening reception.

Aaron Aude, M.S., M.B., National Director, Enterprise Collaboration, Centric Consulting
Ariel Katz, Co-Founder, H1
Good Machine Learning Practices and Predictive Biomarkers in Clinical Development

Never miss an announcement

/* */